wright patterson afb, ohio science update - navy medicine scien… · page 2 science update...
TRANSCRIPT
NAMRU-D attends
54th Society of
Toxicology
1
NAMRU-D Continues to
Investigate Chemical
Exposure
2
NAMRU-D attends
Shoresh Working Group
Meeting
2
NAMRU-D Investigates
Hypoxia Mitigation 3
NAMRU-D’s Past
Quarter Visitors 4
CO’s Corner 5
NAMRU-D is Navy Medicine’s world class, global aeromedical and toxicology research leader. Our efforts and innovative products are aligned with operational requirements to solve the naval and joint warfighter challenges of the future.
VISION
To maximize warfighter performance and survivability through premier aeromedical and environmental health research- delivering solutions to the field, the Fleet, and for the future.
MISSION
INSIDE THIS
ISSUE
Spring Volume 5, Issue II
Science Update
Naval Medical Research Unit Dayton Wright-Patterson AFB, Ohio
By: Dr. Lisa Sweeney
S cientists from Naval Medical Research Unit
Dayton’s (NAMRU-D) Environmental
Health Effects Directorate attended and
presented research during the 54th Annual Meet-
ing of the Society of Toxicology (SOT) held in San
Diego, CA March 22 to 26, 2015. This meeting
brings together approximately 6,900 toxicologists
from over 50 countries to discuss recent advanc-
es and technologies in toxicological research. Dr.
Karen Mumy, Dr. Lisa Sweeney, LCDR Jennifer
Mueller and LCDR Carlis Brown attended from
NAMRU-D. Dr. Sweeney chaired a platform ses-
sion on applications of ToxCast/Tox21 data. Dr.
Sweeney and Dr. Mumy were authors or co-
authors on two poster presentations, both of
which described efforts done in conjunction with
Department of Defense partners.
NAMRU-D scientists teamed up with 711th Hu-
man Performance Wing/RHDJ U.S. Air Force sci-
entists for an evaluation of the potential effects of
“Alcohol-to-Jet” (ATJ) alternative jet fuels. The
authors determined that the appropriate occupa-
tional exposure limits for these fuels are equiva-
lent to those for traditional Air Force jet fuel
(that is, JP-8). Dr. Mumy and Dr. Sweeney of
NAMRU-D were co-authors of this work which
was presented during a poster session entitled,
“Toxicity of Chemical Mixtures.”
In collaboration with U.S. Army, Dr. Sweeney
presented a poster entitled, “Development of a
toxicokinetic model for the insensitive munitions
(IMX) component 2,4-dinitroanisole (DNAN),” in
a session focused on Biological Modeling. IMX
formulations are less susceptible to unintentional
detonation than conventional munitions, but their
potential hazard to humans is unknown. Scientists
at NAMRU-D conducted laboratory studies to
evaluate the absorption, distribution, metabolism,
and elimination of DNAN and its more toxic me-
tabolite2,4-dinitrophenol (DNP) in rats. These
data and similar data generated by the Army for
nonhuman primates (rhesus macaques) were used
by Dr. Sweeney to develop preliminary physiologi-
cally based pharmacokinetic (PBPK) models of
DNAN and DNP in rats, macaques, and (by ex-
trapolation) humans. The PBPK model was used
to generate estimated human no-effect exposure
levels for DNAN based on no-observed adverse
effect levels determined in laboratory animals.
The human no-effect levels may be used to guide
the selection of occupational and environmental
exposure limits for DNAN.
NAMRU-D Presents at the
54th Annual Meeting of the Society of Toxicology:
Alternative Jet Fuel and Insensitive Munitions Research
Dr. Lisa Sweeney presented
her research on the
Development of a
Toxicokinetic Model for
Insensitive Munitions (IMX)
Component 2, 4-
Dinitroanisole at the 2015
Society of Toxicology (SOT)
held March 22 - 26 in San
Diego, CA. Dr. Sweeney is a
Senior PBPK Toxicologist at
NAMRU-D and has attended
the annual SOT meeting
since 1995.
Page 2 Science Update
Investigating Chemical Exposure
at High Altitudes in High Performance Aircraft By: LCDR Carlis Brown & Dr. Deirdre Mahle (U.S. Air Force 711 HPW/RHDJ)
The USAF has been identifying potential contributing factors to epi-
sodes of suspect hypoxia seen in pilots during training missions. In-
flight emergencies with high performance aircraft indicate a gap in our
knowledge or understanding of stressors in the environment and
impact on physiology and/or toxicology. The 711th Human Perfor-
mance Wing (HPW), Molecular Bioeffects Branch has teamed with
NAMRU-D to further investigate identified data gaps for chemical
exposure at high altitudes. One of the uncertainties is the effects of
volatile organic chemicals (VOCs) that have been detected as a cock-
pit contaminant, of which toluene is one example. Toluene is a
chemical with a good scientific exposure database that can easily be
measured in blood and tissues and it has a known physiologically
based pharmacokinetic (PBPK) model for the human exposure as well
as a corollary PBPK model for a rat. In addition, toluene has been
shown to have a link to hypoxia in some studies which increases its
relevance to this study. NAMRU-D was asked to develop a system
that could simulate the inhalation exposure of toluene at high alti-
tudes in an animal model. Such a system would duplicate conditions
experienced in flight and allow the AF to determine whether or not
changes in altitude will significantly increase the uptake of VOCs
compared to exposures at normal ambient atmospheres.
NAMRU-D Attends 2015 Shoresh Working Group Meeting in Israel
Left to right: Dr. Deidre Mahle, Mr. Richard James, and LCDR Carlis Brown
have been collaborating to investigate chemical exposure at high altitudes in high performance aircraft.
By: CDR Michael Lowe
O n March 13-21, 2015 members of Naval Medical Research
Unit Dayton’s (NAMRU-D) Aeromedical scientific research
staff attended and presented at the Shoresh Working
Group Meeting in Ramat Gan, Israel as invited members of the U.S.
Department of Defense/Israeli Defense Forces Aeromedical
Working Group. CDR Michael Lowe, Head, Biomedical Science
Department, NAMRU-D and Dr. Michael Reddix, Senior Research
Psychologist at NAMRU-D, presented three of the four NAMRU-D
briefs during the 17th Shoresh meeting. Dr. Richard Arnold,
Aeromedical Research Director, NAMRU-D phoned in to the
meeting to present NAMRU-D’s command overview. This is the
first Shoresh meeting to include the U.S. Air Force and U.S. Navy
and also the first to look at aeromedical research priorities.
Various topics and issues regarding challenges of operating in the
extreme aerospace environment were discussed. Dr. Reddix
covered Simulation of Aviation Illusions and Advanced
Computerized Color Vision Screening. NAMRU-D’s hypoxia
research, specifically exposure sequel, recovery and mask based
sensors was presented my CDR Lowe. The hypoxia brief included
accomplishments with initial collaborations in foreign comparative
testing featuring the Israeli company Elbit. This work presents a
solid starting point for future collaborations in hypoxia and other
aeromedical domains is the current the U.S. and Israel joint effort
investigation on mask sensors in hypoxia.
NAMRU-D’s fatigue laboratory, Disorientation Research Device,
various cognitive tests, EEG capabilities, and other physiological
measures provide
considerations for future
jointness. In fact, at the
end of the meeting the
Aeromedical topics for
possible collaboration and
inclusion in the final
working group document
for action items were
produced, prioritized, and
presented to the Surgeon
Generals on the last day.
Three NAMRU-D centric
topics made the list of 11
items of which CDR Lowe is the NAMRU-D point of contact for
each. These focal areas were: 1) Spatial Disorientation, 2) Hypoxia,
and 3) Fatigue.
As a result of the meeting the foundation is being laid through
mutually beneficial information exchanges and potential research collaborations with no expectation for funding exchanges. .
NAMRU-D’s attendance at the working group symbolized the first
step in forming a collaborative relationship with Aeromedical
entities in Israel and significantly builds upon the foundations of the
prior joint work on hypoxia sensors with Elbit. CDR Lowe strongly
recommended that NAMRU-D attend the next Shoresh Working
Group and further commits to this working group fully in the
future with an even larger contingent.
CDR Lowe and Dr. Reddix at a
function during the 2015 Shoresh Working Group Meeting .
Page 3 Science Update
NAMRU-D Continues to Investigate Hypoxia Mitigation
By: Dr. Jeffrey Phillips
N aval Medical Research Unit
Dayton’s hypoxia laboratory
focuses both on quantifying
the performance effects of hypoxia
and identifying emerging technologies
to provide fail-safe hypoxia
mitigation. The hypoxia lab is staffed
with experimental psychologists,
physiologists, and biomedical
engineers. NAMRU-D Investigators
have executed numerous studies
evaluating off-the-shelf biomedical
sensors for their ability to reliably
detect an impending hypoxic threat
before the operator experiences
significant performance degradation.
Technologies evaluated include near
infrared spectroscopy, pulse
oximetry, reflectance pulse
oximetry, eye tracking, and
pupilometry.
Both the Air Force and Navy are
currently developing in-mask gas
sensor suites to provide warnings to
aviators when a life support malfunction
occurs. Unfortunately, most
commercial gas sensors do not perform
well in tactical aviation environments
due to the large variations in barometric
pressure, humidity, and temperature.
NAMRU-D houses a state-of-the-art gas sensor testing facility which allows gas
and chemical sensors to be evaluated in
conditions equivalent to the flight
environment. Sensors are tested in a
hypobaric chamber while pressure,
humidity and temperature are
manipulated. To date, twenty-two
sensors have been evaluated in our
facility. This testing has verified that
sensor sensitivity and specificity
improvements are still required before
they can reliably provide significant
hypoxia mitigation in-flight.
The NAMRU-D hypoxia team has also
conducted multiple studies to model the
onset of hypoxia performance effects as
well as the recovery of performance
following hypoxia exposure. Breaking
with traditional teaching, NAMRU-D
study results suggest that operators
exposed to hypoxic environments experience significant
performance degradation at a much earlier time point than
predicted by the Time of Useful Consciousness Tables customarily
used for risk assessments. Furthermore, previously unappreciated
subtle performance effects have been
found to persist for hours following
exposure. The most recent study
also found empirical evidence of an
oxygen paradox as subjects
experienced the largest performance
deficits while they were being administered a five minute treatment
with 100% oxygen following hypoxia
exposure. This implies that following
hypoxia exposure, operators could
remain significantly impaired
throughout the remainder of the
flight.
In the coming years, the NAMRU-D
hypoxia lab will continue to conduct
experiments to better understand the
performance effects of hypoxia, to
test hypoxia-mitigation sensors for
their ability to perform in the tactical
flight environment, and to identify a
hypoxia recovery gas mixture that will
provide quick recovery from hypoxia
exposure without further
compromising performance.
Small Hypobaric Environmental Chamber for sensor testing in aviation-relevant environmental conditions.
The chamber can vary pressure, temperature, humidity, & airflow on sensors of interest.
Dr. Jeffrey Phillips (back right) explains to CAPT Burghardt, PMA-202 (back left) NAMRU-D’s
capabilities to further investigate hypoxia mitigation during the CAPT’s visit on 19 March, 2015.
Page 4 Science Update
Becker, W.J., Geyer, D.J., Gomez, K., & Littman, E.M. (2015, May). Pharmacokinetics and Efficacy of Intranasal Scopolamine Spray. Poster presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Bradley, J.L., Reddix, M.D., Folga, R.V., & Tapia, M.L. (2015, May). Laser-Pointer Illumination Events in Naval Aviation Operations. Presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Caldwell, J.A. & Caldwell, J.L. (2015, May). Understanding and managing fatigue in aviation. Workshop at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Caldwell, J.L. (2015, May). The evidence base for use of modafinil to mitigate fatigue. Workshop at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Caldwell, J.L. (2015, May). Aviation Fatigue Countermeasures Pat II: Advances in Fatigue Management. Workshop at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Drummond, L.A., Funke, M.G., Phillips, J.B., Robinson, F.E., Warner, S.W., Geyer, D.J., & Gomez, J. (May, 2015). Recovery from Hypoxic Exposure. Presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Funke, M.G., Gomez, J., Phillips, J.B., Lee, M.C., Wright, & Becker, W.J. (2015, May). Performance Costs Associated with Modifications to the Oxygen Delivery Schedule of the On-
Board Oxygen Generating System. Poster presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida. Gao, H., Reddix, M.D., & Kirkendall, C. (2015, May). Can Operationally-relevant accuracy and reaction-time metrics guide the development of color-vision standards?. Presentation at
85th Annual Aerospace Medicine Association Conference, Orlando, Florida. Hartzler, B.M. (March, 2015). Predicting performance during chronic sleep loss: Identification of factors sensitive to individual fatigue resistance. Technical Report retrieved
from Defense Technical Information Center.
Hartzler, B. M., Chandler, J.F., & Levin, C.B.S. (2015, May). Identification of measures and moderators to improve prediction of impairments due to chronic sleep loss. Poster
presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Littman, E.M., Lawson, B., Brill, J.C., & Rupert, A. (May, 2015). Near-Future Technological Countermeasures for Spatial Disorientation in Flight. Presentation at International Symposium on Aviation Psychology.
McGowan, K.J., Gao, H., & Whitwell, K.J. (May, 2015). United States Naval Aerospace Optometry. Presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
Patterson, F.R., Williams, H.P., Arnold, R.D, & Folga, R.V. (May, 2015). Aviator Black Hole Illusion: Validation Training Countermeasures for Newly Identified Causal Factors.
Presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida. Phillips, J.B., Robinson, F.E., Drummond, L. A., & Funke, M.G. (May, 2015). Time of Useful Performance: A Complement to the Time of Useful Consciousness Table. Presentation at
85th Annual Aerospace Medicine Association Conference, Orlando, Florida. Phillips, J.B., Grigsby, C., Mayes, R., & Tripp, L. (May, 2015). In-Flight Hypoxia: From Sensors to Biomarkers. Presentation at 85th Annual Aerospace Medicine Association
Conference, Orlando, Florida. Sweeney, L.M., Sommerville, D.R., Channel, S.R., Sharits, B.C., Gargas, N.M., and Gut, C.P., Jr. (2015). Evaluating the validity and applicable domain of the toxic load model:
impact of concentration vs. time profile on inhalation lethality of hydrogen cyanide. Regul. Toxicol. Pharmacol. 71:571-584.
Williams, H.P., Littman, E.M., Folga, R.V., & Patterson, F.R. (May, 2015). Field of view evaluation for flight simulators used in spatial disorientation training. Presentation at 85th Annual Aerospace Medicine Association Conference, Orlando, Florida.
NAMRU-D Products & Presentations
03.19.2015. CAPT Andrews, NAMRU-D Commanding Officer (left) introduced
Brigadier General Payne, AFMOA (right) to NAMRU-D’s Disorientation Research Device. CDR Folga (2nd on right) briefed the devices capabilities. Brigadier
General Timothy Jex, 711 Human Performance Wing Commander (center) accompanied Brigadier General Payne’s tour.
NAMRU-D’s Visitors
03.19.2015. Dr. Jeffrey Phillips demonstrates the functions of the head mounted sensors connected to an
Reduced Oxygen Breath Device to CAPT Burghardt, PMA-202 during a visit to the NAMRU-D facilities.
04.23.2015. NAMRU-D hosted a
visit from Environmental Tectonics Corporation (ETC) Board of
Directors to observe a motion demonstration of NAMRU-D's
Disorientation Research Device. Left to right: CAPT Lee, XO; H. F.
"Gerry" Lenfest, Chairman of the Board of Directors; CAPT Andrews,
CO; Robert L. Laurent, Jr., Chief Executive Officer and President;
CDR Folga; and Winston E. Scott, Director. Right to left: Linda J. Brent;
Director and Roger Colley, Director.
04.23.2015. CDR Folga highlights the Disorientation Research Device’s future
applications for the safety of the war fighter to Environmental Tectonics Corporation ETC Board of Directors.
Science Update Page 7
It is now just past Memorial Day as I write this spring edition and the opportune time to reflect
on our fallen warriors and their ultimate sacrifice. Our mission is all about them. Let their
death be not in vain, but a spark to ignite motivation to make the future better and safer for
those in harms way. All 75 personnel at NAMRU-D know their unique mission, but even more
importantly there is a collective understanding and selfless commitment that we exist for the
joint warfighter. All of our science and efforts are aligned with operational requirements and
our products can and do make a difference in the performance and survivability of those on the
battlefield. Even basic Research & Development (R&D) can be the foundation for a future
cutting edge solution in any operational setting.
Despite the obstacles of bureaucracy, over-regulation, and limited/uncertain funding, successful
R&D starts with an idea. At NAMRU-D, our scientists have ideas that are based on fleet
experience and operational input. That idea needs to be fueled not only by passion and
persistence, but will have to grow and ideally be put to use in an operational setting and applied
by the warfighter. It is during this growth phase that our scientists sprinkle on some intellect,
creativity, teamwork, jointness, collaboration, and yes a touch of luck to finish the main course
and satisfy the appetite of our eaters in the fleet.
This Science Update covers only a 3 month snapshot of life at NAMRU-D and showcases some of our toxicological and
aeromedical accomplishments, international involvement with Israel, and the constant, high visible tours of VIPs and high
ranking officials and agencies. What is not covered is the mindset, motivation, and professionalism of the NAMRU-D team
that make the R&D into a way of life with the pursuit of that product or system that will ultimately reach the warfighter and
maybe someday save lives. I salute those who died for our freedom and commend those who commit their lives to R&D in
support of our heroes. NAMRU-D stands ready for ideas, sound science, and continued growth of capabilities to support
our nation’s finest.
Commanding Officer’s Corner
Captain Jeffrey M. Andrews,
MSC, USN
Commanding Officer
Naval Medical Research Unit Dayton
Wright-Patterson Air Force Base
2624 Q Street, Building 851, Area B
WPAFB, OH 45433-7955
Phone: 937-938-3872
Fax: 937-904-8814
www.med.navy.mil/sites/nmrc/Pages/namrud
Commanding Officer
CAPT Jeffrey Andrews, MSC, USN
Executive Officer
CAPT Rees L. Lee, MC, USN
Naval Medical Research Unit Dayton is on Facebook!
http://www.facebook.com/pages/Naval-Medical-Research-Unit-Dayton/460131294047899?ref=hl
Taking the Helm of Navy Medicine’s
Aeromedical & Environmental Health Research